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Deschamps et al., page 5; Dannemann et al., page 22
Interactions with the environment have shaped the course
of human history. Movement out of Africa and into Europe
and Asia presented several challenges to early humans.
In addition to fending off predators, early humans relied
upontheir immunesystems tocounter attacks fromavariety
of pathogens. Just how early immune systems adapted to
such a rapidly changing environment has been a source of
much speculation and conjecture. Now, using complemen-
tary approaches, Deschamps et al. and Dannemann et al.
have uncovered signatures of selection and evidence of
introgression from the Neandertal and Denisovan genomes
in human innate-immunity genes, most notably those en-
coding the toll-like receptors. The innate immune system
serves as afirst lineofdefense againstpathogensbydetecting
non-self-proteins and triggering downstream-signaling cas-
cades.Moreover, unlike theadaptive immunesystem,which
relies on a complex system of somatic and acquired
variation, the proteins involved in the innate immune
response are encoded entirely in the germline. These find-
ings suggest that admixture with archaic humans played a
key role in shaping the modern human immune system.
Of course, pathogens evolve quickly, and so it will be inter-
esting to determine exactly what role these introgressed
alleles continue to play in shaping the human immune
response.Not So Fast for Non-invasive Prenatal Testing
Lo et al., page 34
Non-invasive prenatal testing (NIPT) could potentially
offer the ability to detect any number of fetal genetic ab-
normalities while also limiting the risk inherent to other
invasive prenatal diagnostic procedures given that it only
requires a sample of maternal blood. NIPT is widely used
for the detection of large chromosomal abnormalities,
including aneuploidy; however, the utility of NIPT in
detecting unknown, smaller chromosomal abnormalities
is unclear. In this study, Lo et al. carefully examined the
sensitivity of NIPT to variation in read depth, fetal fraction,
and copy-number variant (CNV) size. In samples with
known sub-chromosomal abnormalities, reduced fetal
fraction was identified in both false-positive and false-
negative results, and deeper sequencing was required for1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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Thaccurate calling of some samples. Using standard
sequencing depth and low fetal fraction dramatically
reduced sensitivity, suggesting that the predictive value
of NIPT might be negligible in comparison to that of
more invasive diagnostic methods when fetal abnormal-
ities are detected by sonogram. Together, these data indi-
cate that NIPT is not a reliable method for genome-wide
detection of sub-chromosomal abnormalities smaller
than 6 Mb. As methods for determining fetal fraction are
refined and routine sequencing depths increase, perhaps
using NIPT to detect small CNVs will be more promising
for routine clinical prenatal care; but for now, it appears
that clinical utility remains limited.Looking beyond the Exome in ASD
Turner et al., page 58
Recent advances in technology have enabled researchers to
achieve unprecedented insight into the genetic architec-
ture of autism spectrum disorder (ASD). Rare, de novo sin-
gle-nucleotide variants (SNVs) and copy-number variants
(CNVs) are thought to contribute to nearly one-third of
simplex ASD cases. Despite all of these new insights, how-
ever, a large percentage of ASD cases (~60%) continue to
lack an obvious genetic diagnosis. In this issue, Turner
et al. utilized whole-genome sequencing (WGS) to explore
in greater depth the genetic architecture of ASD. Notably,
their analysis revealed an enrichment of rare and de
novo variants—SNVs, indels, and CNVs—within putative
brain-specific regulatory regions. In particular, the authors
highlight the need to better explore the role of small CNVs,
those that alter single exons or regulatory elements, in ASD
etiology. It is still early days for WGS-based analysis of
complex traits, and boosting the accuracy and specificity
of variant calling will require much more work. As in pre-
vious studies, Turner et al. demonstrated that WGS-based
analysis outperforms WES in its ability to detect both cod-
ing and noncoding regions. As the cost of WGS decreases
and technical expertise increases, expect to see many
more WGS cohort studies.Therapeutic Flexibility of CRISPR/Cas9
Wojtal et al., page 90
During the past year, genome editing in humans has
rapidly shifted into the realm of possibility thanks to they of Human Genetics. All rights reserved.
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introduction of the CRISPR/Cas9 system. Given the flexi-
bility of the technology and the unique genetic alterations
across affected individuals with a certain disease, the range
of genetic conditions that could be treated by CRISPR/
Cas9-based approaches is unclear. In this study, Wojtal
et al. explore some of the potential therapeutic avenues
in disorders that might be amenable to CRISPR/Cas9
genome-engineering technology. Using cell lines from in-
dividuals affected by Duchenne muscular dystrophy
(DMD), the authors used single guide RNAs targeting the
CRISPR/Cas9 system to specific regions of the genome to
increase the expression of UTRN, a gene whose expression
has been demonstrated to ameliorate DMD symptoms,
and also to remove an exon in DMD. All of this led
to normalized DMD expression. A dominant-negative
FGFR3 allele that is associated with achondroplasia was
also eliminated, demonstrating that this technology can
reduce the expression of disease-associated alleles while
leaving wild-type alleles intact. Lastly, Wojtal et al. used
CRISPR/Cas9 to remove a duplication of MECP2, a gene
located on the X chromosome. Stretching the CRISPR/
Cas9 system to fit various disorders might be limited
only by our understanding of the allele characteristics
and biology of a given disease, indicating that the develop-
ment of gene-editing therapeutic modalities might be on
the horizon.2 The American Journal of Human Genetics 98, 1–2, January 7, 2016Mammalian Differences in Meiotic Recombination
Gruhn et al., page 102
Meiotic recombination occurs through resolving double-
stranded breaks and results in crossover (CO) sites. These
sites can also act as synaptic initiation sites (SISs). Although
this phenomenon is well studied in organisms including
fungi, plants, and insects, it is unclear whether the same
mechanisms are used in mammals. In this study, Gruhn
et al. characterized the SISs and CO sites in human and
mouse spermatocytes and oocytes across a subset of chro-
mosomes. Patterns of synapsis differed between males and
females and between humans and mice. For example, in
human males, synapsis usually originated at a single site
in the subtelomeric region of each chromosomal arm, but
in human females, multiple SISs were observed and were
frequently identified near the centromere. Although more
SISswere identified in females, in general, the number corre-
latedwith the sizeof thechromosome. Inmice,multiple SISs
were observed across the chromosomes in both males and
females. Examination of proteins associated with CO sites
in both humans and mice suggested that synapsis and CO
sites are correlated, but not an exact match. Taken together,
these data suggest the existence of sex and species differ-
encesbetweenmammalsandotherorganismsandhighlight
the complexity of mammalian meiotic recombination.
